Healthcare - Medical - Instruments & Supplies - NYSE - US
$ 89.22
-1.69 %
$ 4.48 B
Market Cap
37.02
P/E
Price Target
Average
21.33%
Revenue Forecast
Estimate
8.49%
EBIT
Estimate
5.50%
Net Income
Estimate
34.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Haemonetics Corporation
Wall Street analysts predict an average 1-year price target for HAE of $108 , with forecasts ranging from a low of $85 to a high of $120 .
HAE Lowest Price Target
Wall Street Target
85 USD
-4.73%
HAE Average Price Target
Wall Street Target
108 USD
21.33%
HAE Highest Price Target
Wall Street Target
120 USD
34.50%
REVENUE FORECAST
Revenue Forecast Chart HAE
EBIT FORECAST
EBIT Forecast Chart HAE
NET INCOME FORECAST
Net Income Chart HAE